Financial reports
10-Q
2020 Q2
Quarterly report
5 Aug 20
10-Q
2020 Q1
Quarterly report
6 May 20
10-K
2019 FY
Annual report
27 Feb 20
10-Q
2019 Q3
Quarterly report
30 Oct 19
10-Q
2019 Q2
Quarterly report
7 Aug 19
10-Q
2019 Q1
Quarterly report
9 May 19
10-KT
Annual report (with FYE transition)
25 Feb 19
10-Q
2019 Q1
Quarterly report
7 Nov 18
10-K/A
2018 FY
Annual report (amended)
29 Oct 18
Current reports
8-K
Completion of Acquisition or Disposition of Assets
23 Oct 20
8-K
Other Events
21 Sep 20
8-K
Departure of Directors or Certain Officers
17 Sep 20
8-K
Gilead Sciences to Acquire Immunomedics
14 Sep 20
8-K
Approval enhances long-term supply of Trodelvy
17 Aug 20
8-K
Immunomedics Reports Second Quarter 2020 Results and Provides Corporate Update
5 Aug 20
8-K
The safety profile of Trodelvy was consistent with the FDA-approved label and no new safety signals were observed
6 Jul 20
8-K
Departure of Directors or Certain Officers
18 Jun 20
8-K
Immunomedics Announces Leadership Change and Provides Business Update Amid COVID-19
27 May 20
8-K
Departure of Directors or Certain Officers
7 May 20
Registration and prospectus
15-12G
Securities registration termination
2 Nov 20
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Oct 20
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Oct 20
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Oct 20
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Oct 20
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Oct 20
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Oct 20
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Oct 20
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Oct 20
POS AM
Prospectus update (post-effective amendment)
23 Oct 20
Proxies
DEFA14A
Additional proxy soliciting materials
27 May 20
DEFA14A
Additional proxy soliciting materials
27 Apr 20
DEF 14A
Definitive proxy
27 Apr 20
PRE 14A
Preliminary proxy
15 Apr 20
DEF 14A
Definitive proxy
30 Apr 19
DEF 14A
Definitive proxy
2 Mar 18
DEF 14A
Definitive proxy
5 Jun 17
PRER14A
Preliminary revised proxy
2 Jun 17
PRE 14A
Preliminary proxy
26 May 17
DEFA14A
Additional proxy soliciting materials
3 Mar 17
Other
EFFECT
Notice of effectiveness
30 Oct 20
EFFECT
Notice of effectiveness
30 Oct 20
EFFECT
Notice of effectiveness
30 Oct 20
EFFECT
Notice of effectiveness
30 Oct 20
EFFECT
Notice of effectiveness
30 Oct 20
EFFECT
Notice of effectiveness
30 Oct 20
EFFECT
Notice of effectiveness
30 Oct 20
CORRESP
Correspondence with SEC
2 Oct 20
UPLOAD
Letter from SEC
30 Sep 20
UPLOAD
Letter from SEC
30 Sep 20
Ownership
SC 13G/A
Point72 Asset Management, L.P.
16 Feb 21
SC 13G/A
BlackRock Inc.
9 Nov 20
4
William Fricker
27 Oct 20
4
Behzad Aghazadeh
23 Oct 20
4
Usama Malik
23 Oct 20
4
Scott A Canute
23 Oct 20
4
Robert Azelby
23 Oct 20
4
PETER BARTON HUTT
23 Oct 20
4
LORETTTA M ITRI
23 Oct 20
4
Kurt J. Andrews
23 Oct 20